Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

Health Science

Vivos Therapeutics (VVOS.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Vivos’ mmRNA (modified mandibular Repositioning Nighttime Appliance) device, not to be…
Trillium Therapeutics (TRIL.V) announced today that the Company has entered into a definitive agreement under which Pfizer Inc. will acquire Trillium.     “We’re delighted to announce Pfizer’s proposed…
Jamaica, farewell At first glance, I didn’t know what to make of Aion Therapeutics (AION.C). There are a few moving parts, it’s a psychedelics/cannabis hybrid deal with a focus…
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been…
Bioasis Technologies (BTI.V) hired Shadow Lake Group, and affiliate, SLG Europe BV, as a business development adviser earlier this week, according to a press release.   This one’s a…
Sixth Wave Innovations (SIXW.C) announced that it has improved the sensitivity and capability of its leading-edge nanotechnology, allowing it to detect the presence of the SARS-CoV-2 at levels below…
Psyence Group (PSYG.C) started online sales and distribution for their Goodmind line of functional mushroom products today, according to a press release. These mushrooms make broad use of adaptogens,…
Mydecine Innovations Group (MYCO.NE) announced they have signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine. The research will be led by Dr. Matthew Johnson…
PharmaCyte Biotech (PMCB.Q) released a statement from Kenneth L. Waggoner, the Chief Executive Officer of PharmaCyte, on August 16, 2021. In this statement, Mr. Waggoner comments on the Company’s…
Revive Therapeutics (RVV.C) announced they are entering into an exclusive license agreement with Puerto Rico Science Technology and Research Trust (PRSTRT)  for the intellectual property titled ‘Biologically Active Ganoderma…